The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 35 results:
Author [ Title(Desc)] Type Year
Filters: Author is Vyzantiadis, Timoleon-Achilleas  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Ioakimidou, A., Vyzantiadis T-A., Tragiannidis A., Arabatzis M., Papageorgiou T., Velegraki A., et al. (2011).  Candida hellenica var. hellenica as a possible cause of respiratory infection in a child with acute myeloid leukemia.. Med Mycol. 49(7), 771-4.
Papadopoulou, A., Alvanou M., Koukoulias K., Athanasiou E., Lazaridou A., Savvopoulos N., et al. (2019).  Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.. Bone Marrow Transplant. 54(12), 1963-1972.
Theodoridou, S., Balassopoulou A., Boutou E., Delaki E-E., Yfanti E., Vyzantiadis T-A., et al. (2020).  Coinheritance of Triplicated Alpha-Globin Gene and Beta-Thalassemia Mutations in Adulthood: Ten Years of Referrals in Northern Greece.. J Pediatr Hematol Oncol. 42(8), e762-e764.
Markantonatou, A-M., Samaras K., Zachrou E., & Vyzantiadis T-A. (2020).  Comparison of Four Methods for the Susceptibility Testing of Dermatophytes.. Front Microbiol. 11, 1593.
Theodoridou, S., Teli A., Yfanti E., Vyzantiadis T-A., Theodoridis T., & Economou M. (2018).  Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -α/αα Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling.. Hemoglobin. 42(2), 129-131.
Theodoridou, S., Vyzantiadis T-A., & Vlachaki E. (2018).  Compound Heterozygosity for Silent Cap +1570 (T>C) (HBB: c*96T>C), Codon 39 (C>T) (HBB: c.118C>T) and the Presence of ααα/αα in Greece. A Case Presentation.. Hemoglobin. 42(3), 194-195.
Papadopoulou, A., Alvanou M., Koukoulias K., Athanasiou E., Lazaridou A., Savvopoulos N., et al. (2019).  Correction to: Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.. Bone Marrow Transplant. 54(12), 2120.
E
Anagnostis, P., Vyzantiadis T-A., Charizopoulou M., Adamidou F., Karras S., Goulis D. G., et al. (2013).  The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.. Thromb Haemost. 110(2), 257-63.
Chatzivasileiou, K., Kotsiomiti E., & Vyzantiadis T-A. (2019).  Effectiveness of Denture Cleansers on Removal of Adherent Candida albicans Cells from Denture Base Acrylics of Various Roughness.. Int J Prosthodont. 32(2), 196-197.
Bouziana, S., Tziomalos K., Goulas A., Vyzantiadis T-A., Papadopoulou M., Panderi A., et al. (2019).  Effects of major adipokines and the -420 C > G resistin gene polymorphism on the long-term outcome of patients with acute ischemic stroke.. Int J Neurosci. 129(10), 978-985.
Kourtidou, C., Rafailidis V., Varouktsi G., Kanakis E., Liakopoulos V., Vyzantiadis T-A., et al. (2023).  Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage.. J Pers Med. 13(3), 
Theodoridou, S., Prapas N., Balassopoulou A., Boutou E., Vyzantiadis T-A., Adamidou D., et al. (2018).  Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants.. Hemoglobin. 42(4), 257-263.
Kourtidou, C., Rafailidis V., Varouktsi G., Kanakis E., Liakopoulos V., Vyzantiadis T-A., et al. (2022).  Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population.. J Pers Med. 12(7), 

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.